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Gene microarrayThe basic helix–loop–helix DNA binding protein Hand2 has critical functions in cardiac development both in
neural crest-derived and mesoderm-derived structures. Targeted deletion of Hand2 in the neural crest has
allowed us to genetically dissect Hand2-dependent defects speciﬁcally in outﬂow tract and cardiac cushion
independent of Hand2 functions in mesoderm-derived structures. Targeted deletion of Hand2 in the neural
crest results in misalignment of the aortic arch arteries and outﬂow tract, contributing to development of
double outlet right ventricle (DORV) and ventricular septal defects (VSD). These neural crest-derived
developmental anomalies are associated with altered expression of Hand2-target genes we have identiﬁed
by gene proﬁling. A number of Hand2 direct target genes have been identiﬁed using ChIP and ChIP-on-chip
analyses. We have identiﬁed and validated a number of genes related to cell migration, proliferation/cell
cycle and intracellular signaling whose expression is affected by Hand2 deletion in the neural crest and
which are associated with development of VSD and DORV. Our data suggest that Hand2 is a multifunctional
DNA binding protein affecting expression of target genes associated with a number of functional interactions
in neural crest-derived cells required for proper patterning of the outﬂow tract, generation of the appropriate
number of neural crest-derived cells for elongation of the conotruncus and cardiac cushion organization. Our
genetic model has made it possible to investigate the molecular genetics of neural crest contributions to
outﬂow tract morphogenesis and cell differentiation.es, University of Toledo, 3000
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Proper function of the four-chambered mammalian heart requires
that oxygenated blood and deoxygenated blood be routed, respec-
tively, to the systemic and pulmonic circulatory systems. The
elegantly structured cardiac outﬂow tract (OFT) fulﬁlls this task. The
OFT is composed of cells derived from both neural crest and
splanchnic mesoderm that collectively generate a properly septated
ascending aorta and pulmonary artery, which is required for postnatal
survival. Cardiac morphogenesis initiates at E7.5 in the mouse where
anterior lateral plate mesoderm migrates towards the midline
forming a linear heart tube. This early tube gives rise to both right
and left atria, the left ventricle, and is deﬁned as the primary heart
ﬁeld. During looping of the primary heart tube, a second distinct
population of pharyngeal mesoderm-derived cells, termed thesecondary heart ﬁeld, contribute to both myocardial and endocardial
components of the right ventricle, interventricular septum, venous
pole and base of the OFT where it connects to the great vessels. In
addition to themesoderm-derived cells, the OFT acquires a substantial
contribution from the cardiac neural crest. A more complete under-
standing of OFT formation might therefore be based in determining
the function of regulatory molecules expressed in both mesoderm-
derived and neural crest-derived components. The basic helix–loop–
helix (bHLH) DNA binding protein Hand2 is of particular interest as it
has critical functions in both mesoderm-derived and neural crest-
derived components of the developing heart.
Hand2 is expressed within cells of both the primary and secondary
heart ﬁelds, as well as cardiac neural crest-derived cells. Cells from
the primary heart ﬁeld contribute to heart formation beginning at the
cardiac crescent stage (E7). Transcripts encoding Hand2 are present
in the cardiac crescent but as cardiac looping initiates (E8) Hand2
expression within the primary heart ﬁeld down-regulates to be
replaced by expression within the forming right ventricle and
OFT (McFadden et al., 2000; Firulli, 2003; Barnes and Firulli, 2009).
Although systemic knockout of Hand2 does not directly affect
development of primary heart ﬁeld-derived structures, phenotypic
anomalies are observedwithin theOFT and right ventricle (Srivastava et
292 K.L. Holler et al. / Developmental Biology 341 (2010) 291–304al., 1995; Srivastava et al., 1997; Thomas et al., 1998) suggesting a
requirement of Hand2 for proper development of these structures.
Expression of Hand2 is also crucial for the formation of several
neural crest-derived structures including sympathetic chain ganglia
(Howard, 2005; Hendershot et al., 2008; Schmidt et al., 2009), cranio-
facial elements (Funato et al., 2009) and the enteric nervous system
(WuandHoward, 2002;Hendershot et al., 2007;Morikawa et al., 2007).
A constellation of congenital heart defects (CHDs) including
ventricular septal defects, aortic arch artery patterning defects, and
aortic and pulmonary valvular defects, is attributed to cardiac neural
crest dysfunction; these disorders represent a substantial proportion
of all observed CHDs (reviewed in Srivastava and Olson, 2000; Snider
et al., 2007; Waldo et al., 1998; Stoller and Epstein, 2005; Lie-Venema
et al., 2007; Mitchell et al., 2007; Obler et al., 2008; Snarr et al., 2008).
These late-stage phenotypes cannot be assessed in systemic Hand2
knockout mice due to early developmental lethality. To better dissect
the molecular mechanisms of Hand2 function speciﬁcally in neural
crest-derived cells important for OFT morphogenesis and indepen-
dent from its function in mesoderm-derived components, we took
advantage of our ﬂoxed-Hand2 mice (Hendershot et al., 2007, 2008).
We targeted deletion of Hand2 in the neural crest using theWnt1-Cre
driver line of mice (Danielian et al., 1998; Jiang et al., 2002). Our
results demonstrate that targeted deletion of Hand2 in the cardiac
neural crest results in embryos with defects in OFT and aortic arch
artery development, which phenocopy documented neural crest-
dependent defects (reviewed in Stoller and Epstein, 2005; Mitchell
et al., 2007; Hutson and Kirby, 2007). Our studies conﬁrm and extend
previously published aortic arch artery defects in a similar but inde-
pendently generated Hand2 conditional allele (Morikawa and
Cserjesi, 2008), by additional analysis of OFT phenotypic anomalies
and analyses of differential patterns of gene expression. We show that
targeted deletion of Hand2 results in double outlet right ventricle
(DORV) and accompanying ventricular septal defects (VSD). By
combining targeted deletion of Hand2 with microarray and ChIP-on-
chip analyses, we have identiﬁed a number of transcriptional
regulators and signaling molecules within the neural crest whose
expression is modulated by loss of Hand2. Moreover, we show that
Hand2 directly regulates a number of genes expressed within the
neural crest suggesting a role for Hand2 in mediating transcriptional
programs that orchestrate cell–cell interactions within the forming
OFT and which affect cell cycle regulation.
Materials and methods
Targeting strategy and mouse strains
All breeding procedures, animal care and experimental protocols
were approved by the Medical University of Ohio (renamed
University of Toledo Health Sciences Campus) animal care and use
committee prior to initiation of this work. Our strategy for targeting
Hand2 is published elsewhere (Hendershot et al., 2007). Our analysis
of Hand2ﬂ/ﬂ mice demonstrates that the mice are fertile, viable and
phenotypically normal; introduction of loxP sites in the 5′ UTR
therefore does not negatively impact transcription at the targeted
locus. Normal levels and patterns of Hand2 expression have been
conﬁrmed by in-situ hybridization and qRT-PCR (Hendershot et al.,
2007, 2008). Both systemic and targeted deletion of Hand2 isTable 1
Antibodies used for immunostaining in this study are listed. The antigen, dilution, and seco
Antigen/antibody Dilution Source Secondary antib
Connexin 40 (rabbit) 1:50 Zymed, Carlsbad, CA Donkey anti-rab
TRITC Donkey a
GFP (chicken) 1:300 Aves Labs, Tigard, OR Donkey anti-ch
Ki-67 (rabbit) 1:200 AbCam, Cambridge, MA Donkey anti-rabembryonic lethal (Srivastava et al., 1997; Hendershot et al., 2008).
To generate embryos older than E11 (Hendershot et al., 2008)
pregnant dams are fed water containing a cocktail of catecholamines
(100 μg/ml L-phenylephrine, 100 μg/ml isoproterenol, and 2 mg/ml
ascorbic acid) beginning at embryonic day (E) 8. This pharmacological
approach allows us to rescue Hand2ﬂneo/ﬂneo and Hand2ﬂ/ﬂ;Wnt1-Cre
embryos from pre-term death, a phenotype observed in other mouse
models in which norepinephrine is absent or expression curtailed
(Hendershot et al., 2007; Lim et al., 2000; Thomas et al., 1995; Zhou
and Palmiter, 1995). Reporter mice were generated as previously
described (Hendershot et al., 2007). Homozygous R26RYFP females
were mated to hemizygous Wnt1-Cre males and Hand2ﬂ/+;Wnt1-Cre
males were mated to Hand2ﬂ/ﬂ;R262YFP females.
Immunocytochemistry and histology
The antibodies used for the current studies are detailed in
Table 1. Embryos were prepared and treated as previously described
(Hendershot et al., 2007, 2008). Brieﬂy, embryos or tissues are
emersion ﬁxed in 4% paraformaldehyde overnight at 4 °C, exten-
sively washed in PBS and stored in 30% sucrose unless otherwise
stated. For analysis of heart development, hearts were removed
in ice-cold PBS, ﬁxed in 10% neutral buffered formalin, dehydrated
through a graded series of ethanol and embedded in parafﬁn.
Parafﬁn sections were prepared and stained with hematoxylin and
eosin (University of Texas, Southwestern Medical center, Molecular
Pathology Core Laboratory) using standard procedures. Frozen
sections of Hand2wt/wt and Hand2ﬂneo/ﬂneo E11 hearts were stained
using a modiﬁed hematoxylin and eosin stain (Sanderson, 1994).
Brieﬂy, tissue sections were post-ﬁxed in 4% paraformaldehyde
(10 min), rinsed in PBS (2×5 min) and stained in hematoxylin
(1 min), followed by washing in running water, differentiation in 1%
HCl in 70% EtOH, bluing in Scott's tap water (3.6 g sodium bicar-
bonate, 20 g magnesium sulphate/litre) with counterstaining in
eosin Y for 10–20 s, followed by dehydration and mounting in
Permount (Fisher Scientiﬁc, Fair Lawn, NJ) or EUKITT (O. Kindler,
Germany). Immunostaining was done according to our established
procedures (Howard et al., 1999; Wu and Howard, 2002; Liu et al.,
2005a,b; Hendershot et al., 2007). Tissue sections were blocked in a
solution containing .1 M Tris, pH. 7.5, 1.5% NaCl, .3% Triton X-100 and
10% horse serum for 3×5 min. Primary antibody is applied in this
same solution but containing 4% horse serum and incubated over-
night at 4 °C. Following washing in .1 M Tris pH 7.5, 15% NaCl,
secondary antibody was applied in this same solution with 4% horse
serum for three hours at room temperature. Sections are then
washed 3×5 min in .1 M Tris, pH 7.5, 15% NaCl and mounted in
Vectashield (Vector Laboratories, Burlingame, CA) or Fluoromount-G
(Southern Biotech, Birmingham, Al). To view sites of antibody bind-
ing in whole embryos (Young et al., 1999; Hendershot et al., 2007,
2008) sampleswere incubated overnight in PBS containing .3% Triton
X-100 with gentle shaking at 4 °C. We used our standard blocking
step and primary antibody was applied as described above and
incubated for two days at 4 °C with gentle shaking. Following
extensive washing secondary antibody was applied and embryos
incubated overnight at 4 °C with shaking. Whole embryos were
mounted on depression slides in Fluoromount-G (Southern Biotech,
Birmingham, AL).ndary antibodies are listed. The source for each antibody is listed.
ody Dilution Source
bit 1:200 Jackson ImmunoResearch, West Grove, PA
nti-rabbit Alexa 647 1:500 Invitrogen, Carlsbad, CA
icken FITC 1:100 Jackson ImmunoResearch West Grove, PA
bit TRITC 1:200 Jackson ImmunoResearch West Grove, PA
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All confocal images were acquired using a Leica Microsystems
multiphoton confocal microscope (TCS SP5). Confocal Z-stack images
were captured using either a 10× objective (n.a.=.3) or 63× (oil
immersion) objective (n.a.=1.4) with 4× software magniﬁcation at
.5 μm (tissue sections) or 1.0 μm (whole-mount) steps. To acquire
images, ﬂuorescent FITC-coupled, TRITC-coupled and AlexaFlour 647-
coupled secondary antibodies were excited using argon, HeNE or 633
laser lines, respectively.
Gene array analysis
For this array (Affymetrix 430 2.0, mouse array) total cellular
RNA was isolated from Hand2wtwt and Hand2ﬂ/del;Wnt1-Cre E10.5
hearts using RNeasy (Qiagen, Valencia, CA) according to manufac-
turer's directions. The RNA samples were submitted to the NIH
Neurosciences Microarray Consortium (Phoenix, AZ, USA; http://
arrayconsortium.tgen.org/np2/home.do;) for array preparation and
analysis. The screen included three biological replicates for each
genotype (3 chips/genotype). Expression and statistical analyses
were compiled using GeneSpring (GX V 7.3.1 (Agilent Technologies,
Santa Clara CA). The signal intensities from each probe set were
normalized at the 50th percentile for each chip; the expression level
for each gene was normalized to the median level across the arrays.
The linear regression for all replicates was greater than .9 indicating
that replicates correlated very well. A list of signiﬁcantly expressed
genes was generated based on a comparison of 3 arrays derived
from control and three arrays derived from mutant hearts. The list
was ﬁltered ﬁrst for the absent genes, secondly for a fold change
cutoff of 2, and thirdly for P value of ≤.05 using Welch's t-test.
Genes whose expression was signiﬁcantly altered by Hand2 deletion
in the neural crest were subjected to network analysis using
GeneGo (St. Joseph, MI), MetaCore and amiGO to group genes based
on function and/or pathway analysis. We chose genes for further
analysis based on their fold change, relationship to Hand2 and cardiac
development.
Real-time RT-PCR
Expression of transcripts encoding proteins identiﬁed in the
gene array analysis were veriﬁed using quantitative reverse
transcription-real time PCR as previously described (Zhou et al.,
2004; Liu et al., 2005b; Hendershot et al., 2008). Brieﬂy, we
calculated the levels of transcript from the Ct values and
normalized them based on expression of GAPDH. A detailed
description of the protocol and equations can be found in Zhou
et al. (2004) or Liu et al. (2005b). Each triplicate sample was
analyzed (in triplicate) using cDNA corresponding to 10 ng of input
RNA isolated from either Hand2wt/ﬂ or Hand2ﬂ/del;Wnt1-Cre E10.5
hearts. cDNA was mixed with Taqman Gene Expression master mix
(Applied Biosystems, Foster City, CA, USA) and premixed (20×)
Taqman probes (5 μM) and primers (18 μm). Forward and reverse
primers (1.1 μM ﬁnal concentration) with 6-FAM (carboxyﬂuores-
cein reporter dye) and a non-ﬂuorescent quencher dye incorporated
at 5′ and 3′ ends, respectively were used for all assays. Primers and
probes were purchased from Applied Biosystems (Foster City, CA,
USA) from their inventory of pre-developed Taqman® Gene
Expression Assays. Triplicate PCR reactions were run and analyzed
using a 7500 Fast Real-Time PCR sequence detection system (Applied
Biosystems); the increase in product is monitored directly and
reﬂects the threshold number of cycles (C) required for a detectable
change in ﬂuorescence based on release of probe. The efﬁciency of
each primer and probe set was determined in separate reactions and
based on the slope of C vs. input cDNA dilution. Efﬁciency values
were ≥1.875 for all transcripts.Chromatin Immunoprecipitation (ChIP) assay
To determine whether Cx40 is a direct Hand2 target, we em-
ployed Chromatin Immunoprecipitation (ChIP) on genomic DNA
cross linked, immunoprecipitated and puriﬁed from H92c cells,
using a protocol modiﬁed from manufacturer's guidelines (Millipore
Corp., Billerica, MA). Brieﬂy, ∼1×106 H9c2 cells (∼75% conﬂuent,
10 cm dish) were cross linked in 1% formaldehyde for 10 min at RT.
Cross linking was quenched in 1 ml of 1.25 M glycine in PBS with
shaking for 5 min at RT. Cells were rinsed twice with ice-cold PBS,
collected to 1.5 ml Eppendorf tubes, and pelleted at 2000×g for
4 min at 4 °C. Cell pellets were washed with 1 ml of PBS containing
protease inhibitors (1 mM phenylmethylsulfonyl ﬂuoride, 1 μg/ml
aprotinin, 1 μg/ml pepstatin, Roche Inc., Madison WI) then resus-
pended in 200 μl of lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris-Cl,
pH 8.1, 1 mM phenylmethylsulfonyl ﬂuoride, 1 μg/ml aprotinin,
1 μg/ml pepstatin). The cell suspensions were incubated on ice
for 10 min and sonicated on ice 4 times, 30 s each, at 1 minute
intervals using a setting of 3 (Fisher Scientiﬁc Model: 550 Sonic
Dismembrator). The appropriate sonication protocol was deter-
mined empirically. Lysates were centrifuged (1000 rpm, 7 min) and
supernatants were added to 1.8 ml of dilution buffer (1.1% Triton
X-100, .01% SDS, 1.2 mM EDTA, 167 mM NaCl, 16.7 mM Tris–HCl,
pH 8.1, 1 mM phenylmethylsulfonyl ﬂuoride, 1 μg/ml aprotinin,
1 μg/ml pepstatin), then pre-cleared with 50 μl of Protein A/G
PLUSAgarose (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) for
1 h with end-over-end rotation at 4 °C. Protein A/G PLUSAgarose
was removed by brief centrifugation and immunoprecipitation was
performed overnight at 4 °C with 5 μg of Hand2 antibody.
The following day, an additional 50 μ1 of Protein A/G PLUSAgarose
was added and the incubation continued for 2 h at 4 °C. Immuno-
complexes were collected by centrifugation at 1000 rpm for 1 min at
4 °C and subjected to sequential 5 minute washes in 1 ml of each of
the following buffers: low salt immune complex wash buffer
(1% Triton X-100, .1% SDS, 2 mM EDTA, 20 mM Tris–HCl, pH 8.1,
150 mM NaCl), high salt immune complex wash buffer (1% Triton
X-100, .1% SDS, 2 mM EDTA, 20 mM Tris–HCl, pH 8.1, 500 mM
NaCl), and LiCl immune complex wash buffer (.25 M LiCl, 1% NP-40,
1% deoxycholate, 1 mM EDTA, 10 mM Tris–HCl, pH 8.1). Precipitates
were washed twice with TE buffer, then eluted twice in 250 μl of
elution buffer (1% SDS, .1 M NaHCO3) for 15 min at RT. The eluates
were pooled and 20 μl of 5 M NaCl was added; the eluates were
subsequently heated at 65 °C for 4 h. Protein was removed from the
samples by addition of 10 μl .5 M EDTA, 20 μl 1 M Tris–HCl, pH 6.5
and 1 μl of 20 mg/ml Proteinase K for 1 h at 45 °C. DNA fragments
were recovered by phenol/chloroform extraction and ethanol pre-
cipitation; 10 μg of yeast tRNA was added to each eluate to aid in
recovery of DNA pellets. Following centrifugation (12,000×g,
20 min at 4 °C), the pellets were resuspended in 50 μl of TE; 1 μl
was used per PCR reaction. PCR primers were as follows: Cx40(F)
ChIP[−1144]: 5′-ACTGTCCCTCAGTTTCCCTG-3′, Cx40(R)ChIP
[−814]: 5′-ACAGAGGGTCAAGGACATGG-3′, Cx40(F)ChIP[−655]:
5′-GAACACTCTGATTGGTGGGG-3′ , Cx40(R)ChIP[− 283]: 5′-
CCAGTGGCTGTCCTTGTTTT-3′, GAPDH: 5′-TCCCACTCTTCCACCTTC-3′,
GAPDH: 5′-CTGTAGCCGTATTCATTGTC-3′. PCR was conducted using
GoTaq polymerase (Promega Corp., Madison, WI) with a 58 °C, 1 min
annealing step over 40 cycles of ampliﬁcation.
ChIP-on-chip
Neural crest-derived cells were FACsorted from 20 E10.5 hearts
isolated from wild-type Wnt1-reporter embryos and samples were
prepared according to themanufacturer's ChIP-chip user's guide (Roche
NimbleGen, Inc. Madison, WI). Brieﬂy, hearts were extensively washed
in ice-cold PBS, incubated in .5% trypsin in CMF-PBS for 15 min and
dissociated into single cells using a ﬁre-polished Pasteur pipette. The
Fig. 1. Cardiac development is affected in Hand2 hypomorph embryos. Whole hearts
were removed from Hand2ﬂ/ﬂ [A] and Hand2ﬂneo/ﬂneo [B] E18.5 embryos and 20 μm
frozen transverse sections were visualized following staining with hematoxylin and
eosin. Misexpression of Hand2 [B] consistently results in enlarged hypoplastic right
ventricles and disorganized trabeculations. Abbreviations: right ventricle (RV), left
ventricle (LV), and aorta (Ao). Scale bars indicate 100 μm [A, B] and 25 m [A1, A2, B1,
B2].
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formaldehyde for 8 min at RT. The cross linking was quenched in
125 mM glycine. The washed cells were ﬁltered through a 70 μm nylon
cell strainer (Falcon#352350, Bedford,MA) and subjected to FACsorting
(BDFacs Aria, BD Biosciences, San Jose, CA); the non-neural crest cells
from the non-sorted sample were used for the controls. The sorted
neural crest cells were lysed and sonicated (Fisher ScientiﬁcModel: 550
Sonic Dismembrator) for 4 rounds for 15 s on a setting of 3 with a one
minute incubation on ice in between each round. The appropriate
settings for sonication were determined on genomic DNA and the
fragment size veriﬁed in a 1% agarose gel. For IP, we used our Hand2
antibody (raised in rabbit) coupled to Dynabeads (M-20, Invitrogen,
Carlsbad, CA). Complexes were allowed to form for 2 h at 4 °C
with rotation and isolated on a magnetic table. Sample DNA was
ampliﬁed according to manufacturer's directions (WGA3, Sigma-
Aldrich, St. Louis, MO) and sent to Roach for processing (2.1×106
Deluxe Promoter Array).
Transfection and luciferase reporter assay
HEK293a cells were grown in DMEM plus 10% FBS supplemented
with L-glutamine, Na-pyruvate and 100 mg/ml Pen/Stryp (Invitrogen,
Carlsbad, CA); cells were transfected when 50% conﬂuent using CaPO4
according to our published procedures (Firulli et al., 1994). In each
well, 2.5 μg of pcDNA-Hand2 and/or pCS2-MT+E12 (plus empty
pcDNA vector to make a total of 5 μg of plasmid DNA) was co-
transfected with 5 μg of Cx40 luciferase reporter (Cx40+pXP2) and
150 ng of Renilla reporter (pRL-CMV) as a transfection control.
Cultures were harvested 48 h after transfection and diluted ∼10 fold
in lysis buffer; 50 μl of this lysate was assayed. Luciferase assays
were performed as previously reported (Xu et al., 2003) using the dual
luciferase assay kit (Promega Corp., Madison, WI) according to
the manufacturer's protocol. Luciferase activities were read using a
96-well microtiter plate luminometer (Thermo Labsystems, Franklin,
MA). Assays were done in triplicate.
Statistics
Data are presented as the mean±S.E.M. unless otherwise stated.
Statistical signiﬁcancewas determined using Student's unpaired t-test
or ANOVA and Bonferroni post hoc test, unless otherwise stated. At
least four embryos were examined for each condition from at least
three different matings unless otherwise stated. For microarray
analysis, three biological replicates were run and each in triplicate.
Results
Hand2 misexpression affects heart development
In order to deﬁne the molecular basis for defects in heart devel-
opment associated with loss of Hand2 function, we generated a
conditional targeted mutation of Hand2 (Hendershot et al., 2007,
2008). For the current studies, we targeted deletion of Hand2
speciﬁcally within neural crest-derived cells by intercrossing our
compound heterozygous ﬂoxed-Hand2 (Hand2f/ldel) mice with mice
expressing Cre recombinase under control of theWnt1 promoter. The
Wnt1-Cre transgene allows ﬂoxed genes to be targeted in the neural
crest (Danielian et al., 1998; Jiang et al., 2000; Brewer et al., 2004;
Hendershot et al., 2008). Because loss of Hand2 expression within
neural crest-derived cells is embryonic lethal between E10 and E11
due to insufﬁcient levels of norepinephrine (Lim et al., 2000;
Hendershot et al., 2008), we routinely feed pregnant dams a cocktail
of catecholamine intermediates beginning at E8 (Lim et al 2000;
Thomas et al., 1995; Zhou and Palmiter, 1995; Kaufman et al., 2003;
Hendershot et al., 2008). This pharmacological rescue makes it
possible to bring embryos to term, allowing assessment of Hand2loss-of-functionwithin neural crest-derived cells and tissues, through-
out late-stage OFT morphogenesis and up to birth. Wnt1-mediated
deletion of Hand2 results in developmental defects in all neural crest-
derived structures dependent upon Hand2 for early aspects of their
development (Hendershot et al., 2007, 2008). Brieﬂy, there is
signiﬁcant loss of sympathetic and enteric neurons, alterations in
neurotransmitter expression and regulation, as well as a number of
defects in cranio-facial development, consequent to the loss of Hand2.
We previously reported that embryos harboring the neomycin
cassette (Hand2ﬂneo/ﬂneo) in their genome misexpress Hand2 resulting
in a Hand2 hypomorph (Hendershot et al., 2008). Interestingly, the
impact of Hand2 under-expression was observed to be tissue
dependent demonstrating both gene dosage and penetrance effects.
The importance of Hand gene dosage for cardiac development is well
documented (McFadden et al., 2005) and this current study conﬁrms
and extends these previous ﬁndings. At E18 we observe differential
effects on heart development in Hand2ﬂneo/ﬂneo embryos compared to
Hand2ﬂ/ﬂ embryos (Fig. 1). In Hand2 hypomorphic (Hand2ﬂneo/ﬂneo)
embryos, under-expression of Hand2 could be affecting neural crest-
derived structures, primary heart ﬁeld myocardium, and/or intraven-
tricular septal myocardium derived from the second heart ﬁeld. In the
cardiovascular system, the neural crest makes contributions to the
aortic arch arteries and OFT. In Hand2ﬂneo/ﬂneo embryos, there were no
obvious developmental defects within the aortic arch arteries (one
embryo had patent ductus arteriosus); ∼50% of hearts examined
showed membranous VSDs (not shown). Development of the right
ventricle is dependent upon Hand2 but independent of the neural crest
(Srivastava et al., 1997; Thomas et al., 1998; Srivastava, 1999).
Development of the right ventricle was affected in all hypomorphic
hearts examined (Fig. 1B). In these hearts ventricular hypoplasia and
disorganized trabeculations indicate likely effects on proliferation and/
or apoptosis of cardiomyocytes. We have previously reported that
Hand2 regulates proliferation of neural crest-derived noradrenergic
neural precursor cells and neuroblasts (Hendershot et al., 2008)
suggesting a potential function for Hand2 in the heart (see data
below). The hypomorph phenotype thus recapitulates some of the
defects observed in Hand2 systemic null embryos (Thomas et al., 1998;
McFadden et al., 2005). Since we were interested in dissecting the
function of Hand2 in cardiac neural crest-derived structures and given
this potential complication, we employed SYCP-Cremice to remove the
neomycin-resistance cassette within our Hand2 conditional allele and
completely rescue these hypomorphic defects (Hendershot et al., 2008).
Fig. 2. Conditional deletion of Hand2 effects outﬂow tract development. Whole hearts
were removed from Hand2ﬂ/ﬂ (WT) [A] and Hand2ﬂ/ﬂ;Wnt1-Cre (−/−) [B, C] embryos,
embedded in parafﬁn and 20 μm transverse sections stained with hematoxylin and
eosin. In all mutant embryos examined (5) we observed membranous VSDs (B, black
arrow) and double outlet right ventricle (C, DORV, arrows). Based on the expression
pattern of GFP in comparable cryosections of E18.5 Hand2wt/wt;Wnt1-Cre/R26RYFP
reporter [D] and Hand2ﬂ/ﬂ;Wnt1-Cre/R26RYFP mutant reporter [E–F] embryo hearts, the
defects that we observe following deletion of Hand2 can be ascribed to neural crest-
derived anomalies. Abbreviations: conotruncus (CT) and aorta (Ao).
Fig. 3. Conditional deletion of Hand2 effects cell–cell interactions and migration of
cardiac neural crest-derived cells. Migrating neural crest-derived cells were visualized
in E10.5 Hand2wt/wt;Wnt1-cre/R26RYFP reporter [A–B] and Hand2ﬂ/del;Wnt1-cre/R26RYFPmutant
reporter hearts [C–D] immunostained for YFP expression in whole-mount. Confocal
optical sections (1 μm) were compressed into a z-stack (∼400 sections) and analyzed.
The pattern of migrating neural crest-derived cells observed within the outﬂow tract of
mutant embryos was strikingly affected by loss of Hand2 expression. Neural crest-
derived cells failed to migrate as a sheet and individual cells appear to have lost
apparent contact with their neighbors routinely observed in control migrating cells
(compare panels B and D). The number of neural crest-derived cells localized within
the conotruncus (white arrows) appears reduced (see Fig. 4) and the patterning of the
AP Prongs is defective in the mutant compared to control hearts. The insets show high
power views of the area indicated by the (*).
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Based on the expression pattern of Hand2 within the cardiac
neural crest, we predicted that deletion of Hand2 speciﬁcally within
this cell population would adversely affect proper development of
outﬂow tract structures. Analysis of Hand2 loss-of-function within the
neural crest consistently demonstrated effects on ventricular septation
and alignment of the great vessels (Fig. 2). We consistently observed
double outlet right ventricle (DORV) with an associated membranous
VSD in all Hand2ﬂ/ﬂ;Wnt1-Cre embryos (Figs. 2B, C) examined. This neural
crest-derived anomaly (DORV) was never observed in Hand2 hypo-
morphic embryos. Analysis of Hand2wt/wt;Wnt1-Cre;R26R/YFPmice (Fig. 2D)
andHand2ﬂ/ﬂ;Wnt1-Cre/R26R/YFPmutant reportermice (Figs. 2E, F) demon-
strates that Hand2will be recombined in the neural crest-derived cells
which contribute to the conotruncus and aortic arch arteries. The effect
of misexpression of Hand2 within the heart therefore depends heavily
upon Hand2 expression levels as well as the identity of the cells where
expression of Hand2 is affected.
Defects in neural crest migration and proliferation
Between days E10 and E13 in the mouse, the neural crest not
only remodels the pharyngeal arches, contributing to the smooth
muscle of the forming arch arteries, but also invades the OFT to
form the septum that divides the aorta and pulmonary trunk
(Conway et al., 1997, 2000; Snarr et al., 2008). We considered that
aberrant migration of neural crest-derived cells into the OFT might
contribute to the VSDs observed in all embryos deﬁcient in expres-
sion of Hand2 in neural crest-derived cells. At E10.5 neural crest-
derived cells have migrated into the OFT traversing approximately
50% of this developing structure (Fig. 3). The patterns of migration
observed in Hand2wt/wt;R26R/Wnt1-Cre and Hand2ﬂ/del;R26R/Wnt1-Cre
E10.5 reporter embryos is strikingly affected by deletion of Hand2.
At this stage of development it is possible to observe the “prongs” of
neural crest-derived cells that will migrate into the truncal cushions
(arrows in Figs. 3A, C) and which contribute to septation of the
aorta and pulmonary arteries. Visual inspection suggests that lossof Hand2 negatively impacts cell migration and/or cell numbers.
There is a dramatic reduction in the number of neural crest-derived
cells within the OFT (compare Figs. 3B, D). The migration of neural
crest-derived cells into the aortic sac and truncus is not only
required for septation but elongation of the conotruncus as well
(Waldo et al., 1999; Epstein et al., 2000; Snider et al., 2007).
Examination of neural crest-derived cells (Figs. 3B, D) actively
migrating into this region suggested that cell–cell interactions are
important. It appears that neural crest-derived cells migrate as a
coherent sheet of cells with the majority of cells being in contact
with their neighbors. In the Hand2ﬂ/del;Wnt1-Cre;R262RYFP hearts we
observe not only fewer cells that have reached the truncus but in
addition they appear to migrate more as individual cells with fewer
contacts with neighboring cells.
Based on our previous ﬁndings indicating that Hand2 is required
to generate the appropriate number of neuronal precursor cells
and neuroblasts in developing noradrenergic sympathetic ganglia
(Hendershot et al., 2008) we counted the number of cells expressing
the proliferation marker Ki-67 at E10.5 in Hand2wt/wt;Wnt1-Cre;R26RYFP
and Hand2ﬂ/del;Wnt1-CreR262RYFP hearts. The number of GFP (YFP)
marked neural crest cells that labeled for immunoreactivity to Ki-67
was determined on 20 μm frozen cross sections at the level of the OFT
(Fig. 4). Cells were counted in the entire outﬂow tract of control and
mutant hearts. In control embryos, the mean number of proliferating
neural crest-derived cells per tissue section in the OFT was 47±6
compared to 10±2 (Pb .01) in the mutant OFT. Based on the number
of neural crest-derived cells (GFP) migrating into and within the OFT,
we observed a signiﬁcant reduction in the proportion of proliferating
cells based on the total neural crest cell population (Fig. 4G); in
Fig. 4. Hand2 affects proliferation of cardiac neural crest-derived cells. To determine if the apparent decrease in neural crest-derived cells migrating within the outﬂow tract of
Hand2ﬂ/del;Wnt1-Cre;R26R/YFP hearts was due to a defect in cell proliferation, we determined the number of neural crest-derived cells expressing the proliferation marker, Ki-67 in E10.5
outﬂow tract ofHand2wt/wt;Wnt1-cre/R26RYFP reporter [A, C, E] and Hand2ﬂ/del;Wnt1-cre;R26RYFPmutant reporter hearts [B, D, F]. Cells were visualized, following immunostaining for Ki-67 (red)
and GFP (green; marks YFP expressing neural crest-derived cells) in 20 μm frozen cross sections. There was no apparent difference in the number of cells expressing Ki-67 localized to
second heart ﬁeld. Visual inspection of the entire set of sections encompassing the developing outﬂow tract indicated a substantial decrease in the number of neural crest-derived cells
(green) and neural crest-derived cells proliferating (green+red) within the outﬂow tract of mutant [B, D] compared to control [A, C] hearts. This result was quantiﬁed [G] by counting
the number of cells co-expressing GFP and Ki-67 over the entire length of the outﬂow tract (N=3 for each genotype). There was a signiﬁcant (Pb .001) decrease in the number of
proliferating neural crest-derived cells in response to targeted deletion of Hand2. [H] The percentage of mitotic ﬁgures did not differ signiﬁcantly in control compared to mutant OFT.
296 K.L. Holler et al. / Developmental Biology 341 (2010) 291–304control embryos 41%±4 of neural crest-derived cells were prolifer-
ating compared to 24%±3 (Pb .05) in the mutant outﬂow tract. This
result suggested possible impact of loss of Hand2 on mitosis. To
determine if the number of cells in mitosis was affected by loss
of Hand2, we counted the number of mitotic ﬁgures in the OFT
of Hand2wt/wt;Wnt1-Cre;R26RYFP and Hand2ﬂ/del;Wnt1-CreR262RYFP E10.5
embryos labeled with Ki-67 (Figs. 4E, F, H). The percentage of mitotic
ﬁgures inHand2ﬂ/del;Wnt1-CreR262RYFPOFTwas not signiﬁcantly different
from control indicating that equivalent numbers of neural crest-
derived cells initiated mitosis; this likely results from problems ineither G1 or S phases of the cell cycle. This suggests that the effects we
observe on proliferation likely reﬂect alterations in the regulatory
mechanisms controlling transit through the various stages of mitosis.
Outﬂow tract defects associated with altered gene expression
In order to directly address the genetic basis of the OFT phenotype
we observe in Hand2ﬂ/del;Wnt1-Cre embryos, we compared the panel of
transcripts whose expression was altered in mutant compared to
wild-type embryos. We screened gene arrays using RNA isolated from
Fig. 5. Functional classes of differentially regulated genes in the hearts ofHand2wt/wt and Hand2ﬂ/del;wnt1-cre embryos. Regulated genes were grouped into 11 functional categories and
graphed as a percentage of the total based on their GeneGo designation. 309 genes were differentially regulated based on analysis of the array data; 79 of these regulated genes did
not have any known function and were eliminated from this analysis [A]. Of the regulated genes, 68 were up-regulated [B] and 162 were down-regulated [C]. A number of down-
regulated genes (17) are associated with cell adhesion; none of the genes in this category was up-regulated. The cytoskeletal-related transcript category contained 16 down-
regulated genes and 2 up-regulated genes. In the transcription factor category, a notable difference in the number of transcripts down-regulated (17) and up-regulated (4) related to
Hand2 was observed. In the kinases/phosphatases category a signiﬁcant number of transcripts (11 up-regulated, 11 down-regulated) were affected by Hand2 deletion. We have
identiﬁed a number of Hand2-target genes in each of these categories that are associated with the developmental anomalies that we observe in embryos with targeted deletion of
Hand2 in the neural crest.
297K.L. Holler et al. / Developmental Biology 341 (2010) 291–304E10.5 Hand2wt/wt and Hand2ﬂ/del;Wnt1-Cre whole hearts. The screen
included three biological replicates for each genotype (9 chips/
genotype). Our results demonstrate that targeted deletion of Hand2
in neural crest-derived cells in the heart signiﬁcantly (Pb .05) affected
expression of 309 identiﬁed transcripts and 56 unidentiﬁed transcripts
regulated minimally by greater than or equal to a 2-fold change
(Fig. S1). The identiﬁed transcripts were associated with 11 functional
classes (Fig. 5A; GeneGo Inc., St. Joseph,MI). Of the identiﬁed regulated
genes, 68 were up-regulated (Fig. 5B) and 162 were down-regulated
(Fig. 5C). Of the identiﬁed genes (309) 79 proteins were identiﬁed but
which have no known function. Of the genes regulated, a notable
fraction is known to affect heart development and/or cardiac function
(Table 2). We validated a set of genes whose apparent function is
associated with some aspect of the morphological or functional
consequences ofHand2deletion; a subset of these geneswere validated
using RNA puriﬁed from cardiac neural crest-derived cells FACsorted
from E10.5 heart showing that our transcript analysis yielded
alterations in expression of neural crest-speciﬁc genes (* in Table 2).
Genes associated with neural crest cell migration
In our initial analysis of the consequences on heart development
due to targeted deletion of Hand2 in the neural crest, we observed
that population of the conotruncus by neural crest-derived cells
was aberrant (Fig. 3). Several genes associated with migration were
differentially expressed in the Hand2ﬂ/del;Wnt-Cre mice. These regu-
lated genes fall into at least three functional networks (Table 2).
We validated genes from each group using qRT-PCR and/or immu-
nostaining. We observed a decrease in transcript encoding Pdgf
(↓3.89); Pdgf has been associated with neural crest cell migration
(Orr-Urtreger and Lonai, 1992). Interestingly, defects in the Pdgf
receptor results in developmental defects in the OFT as well as other
neural crest-derived structures (Morrison-Graham et al., 1992). We
validated integrin α9 (Itga9; ↑2.94) because it has an important
function in angiogenesis (Brooks et al., 1994), which is adverselyaffected in Hand2 mutant embryos (and see Morikawa and Cserjesi,
2008) as well as a potential role in cell migration (Young et al., 2001;
Huang et al., 2005). The integrin subunit α4 is a component of the
α4b1 ﬁbronectin-binding domain, which is one important interac-
tion regulating cell migration (Sheppard et al., 1994; Pinco et al.,
2001), and was up-regulated (↑3.83) in response to deletion of
Hand2. Interestingly, Adam19 (↓2.16) inhibits migration mediated
by α4b1 integrins (Huang et al., 2005). Deletion of α4 integrin is
embryonic lethal in part due to defective development of the
epicardium and coronary vessels (Yang et al., 1995).
The regulation of connexin 40 (Cx40; Gja5) was of particular
interest because it is heart-speciﬁc (Dahl et al., 1995; Kirchhoff et al.,
2000) and associated with both adhesion and cell-cell communica-
tion. Based on the array results, transcripts encoding Cx40 were
down-regulated 24-fold in Hand2ﬂ/del;Wnt1-Cre hearts compared to
control; this transcript was not detectable by qRT-PCR in the linear
range of ampliﬁcation (transcript became detectable at 40 cycles of
ampliﬁcation). We used immunostaining and confocal microscopy
to visualize sites of Cx40 expression on tissue sections of E10.5
OFT (Fig. 6). Interestingly, although we could not detect transcripts
encoding Cx40 there remains a small number of cells (Figs. 6B, D, F,
arrows) that express Cx40 protein in the mutant OFT. The majority of
neural crest-derived cells express Cx40 in the wild-type OFT, a novel
ﬁnding in itself (Figs. 6A, C, E). Connexin 40 is also expressed in some
cells in the second heart ﬁeld-derived component of the conotruncus
in both the control and mutant hearts (white arrows Figs. 6A, B)
validating that neural crest-speciﬁc deletion of Hand2 is revealing a
cell autonomous effect. We further assessed regulation of Cx40
because it has not previously been reported in the neural crest and is
affected cell autonomously by Hand2 loss-of-function.
Hand2 binds to and trans-activates the Cx40 promoter
We sought to validate that a subset of the genes identiﬁed in our
microarray screen represent direct Hand2 transcriptional targets
Table 2
Hand2-target genes.
*Expression veriﬁed by qRT-PCR of FACS-isolated ROSA-YFP cardiac neural crest. For
the ChIP-on-chip the false discovery rate (FDR) is presented. Each reported interval is
considered signiﬁcant and indicative of a potential binding site. Within the three
conﬁdence levels, FDR≤ represents the highest conﬁdence level; FDR N is
the second highest conﬁdence level and FDR is the lowest conﬁdence level
where binding remains statistically signiﬁcant. The primary data for the heart micro-
arrays is available at the NIH microarray consortium website http://np2.ctrl.ucla.edu/
np2/home.do. To navigate to the data, click on the “navigate repository” button and
write Howard under investigator and click go. The project will come up and the data
can be accessed by clicking on the magnifying glass.
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number of putative Hand2-target genes. We analyzed Cx40 in some
detail because Cx40 null mice display membranous VSDs phenotyp-
ically similar to those occurring in our Hand2-loss-of-function
embryos (Kirchhoff et al., 2000) and we found that Cx40
is expressed in cardiac neural crest cells (Fig. 6). A putative cis-
regulatory region for the Cx40 gene has been previously identiﬁed(Seul et al., 1997) and spans bases from−1190 to +121. Initially, we
analyzed this region for E-box (bHLH consensus) binding sites
(CANNTG) and identiﬁed a total of 9 sites 5′ to the Cx40 transcription
start site 5′ to exon 1 (Fig. 7A). For ChIP analysis we used H9c2 cells, a
rat cardiomyocyte cell line which endogenously expresses Hand2
(Zang et al., 2004) and which up-regulates Cx40 expression in
response to Hand2 overexpression (Togi et al., 2006). PCR ampliﬁca-
tion of DNA fragments immunoprecipitated using our Hand2 antibody
revealed that DNA fragments overlapping the proximal (−655 to
−283 bp), but not distal (−1144 to−814 bp) E-box-containing DNA
sequences co-immunoprecipitated with Hand2 (Fig. 7B); the two sets
of primers we designed and tested ﬂank all 9 of the E-boxes in the
Cx40 5′ putative cis-regulatory region. The PCR product band was
TOPO® cloned (Invitrogen, Carslbad, CA) and the sequence veriﬁed as
the appropriate region of Cx40 (not shown). These data suggest
that Hand2 directly binds to the putative Cx40 promoter at E-box
sites located between−655 and−283 bp relative to the transcription
start site. In order to directly demonstrate that this binding could
have functional relevance, we conducted trans-activation studies to
conﬁrm that Hand2 can regulate Cx40 transcriptional activity. We
used a reporter construct (generously provided by Benoit Bruneau,
Gladstone Institute of Cardiovascular Disease) containing sequence
corresponding to bases−1068 to +121 of the Cx40 gene, that drives
expression of a luciferase cassette (Bruneau et al., 2001); this was co-
transfected with Hand2 and/or E12 expression constructs into HEK
293 cells (Fig. 7C). While expression of neither Hand2 nor E12 alone
was sufﬁcient tomodulate Cx40-luc reporter expression, expression of
both factors together up-regulated Cx40-luciferase activity (∼2.2 fold)
over baseline (Pb .001). These results indicate that Hand2 and its
bHLH dimer partner, E12, can positively regulate gene expression
from the Cx40 promoter. Together, these results indicate that Cx40 is a
direct target of Hand2 within the cardiac neural crest.
We validated (qRT-PCR) an additional subset of genes, identiﬁed
in the array screen, that appear in one or more of the functional
pathways associated with cell–cell interaction and/or adhesion
(Table 2; validated genes are shown in blue). In addition to qRT-PCR
and ChIP, we also performed a ChIP-on-chip screen on FACsorted
cardiac neural crest-derived cells (Table 2) to determine which of the
validated genes are potentially neural crest-speciﬁc Hand2 direct
transcriptional targets.
Genes associated with neural crest cell cycle
We validated a subset of genes associated with cell cycle because
of the signiﬁcant reduction in proliferation that we observe (Fig. 4)
whenHand2 is deleted in neural crest-derived cells (Hendershot et al.,
2008). The genes that we validated, based on qRT-PCR and ChIP-on-
chip, include cdk6 (↑2.53), Insm1 (↓20.7 array vs. undetectable qRT-
PCR); each of these genes is associated with some aspect of cell
proliferation and/or known Hand2-related genes. Several classical
“cell cycle” genes are differentially regulated in the absence of Hand2.
The most highly regulated gene in the array was cyclin B1 interacting
protein 1 (Ccnb1ip1; ↑37.42). The protein coded for by this gene is a
Ring ﬁnger protein. It is a member of a group of B-type cyclin E3
ubiquitin ligases that also has cyclin-dependent kinase and cyclin-
dependent phosphorylation sites (Toby et al., 2003). This protein
interacts with cyclin B1, an important checkpoint regulator of cell
cycle progression, and causes its degradation (Toby et al., 2003).
Overexpression of Ccnb1ip1 substantially reduces expression of cyclin
B1 resulting in decreased proliferation (Toby et al, 2003). This protein
also has been shown to affect migration and metastasis (Singh et al.,
2007) potentially linking cell cycle with migration; functions which
are both effected by deletion of Hand2. It is interesting to note that
none of the cyclin proteins was identiﬁed in our array but several
cyclin-dependent kinases or interacting proteins were. Cyclin depen-
dent kinase 6 (↑2.53) was increased. Cyclin dependent kinase 6 is a
Fig. 6. Connexin 40 expression is decreased by targeted deletion of Hand2 in the
neural crest. Expression of connexin 40 was examined in the outﬂow tract of
Hand2wt/wt;Wnt1-Cre;R26R/YFP [A, C, E] and Hand2ﬂ/del;Wnt1-Cre;R26R/YFP [B, D, F] E10.5
cryostat sections encompassing the entire outﬂow tract. Tissue sections (20 μm)
were immuno-labeled for expression of YFP (reporter, green) and connexin 40 (red).
The entire outﬂow tract was imaged at 20× and 63×; .5 μm optical sections were
compressed in the z-plane and assessed. Ten pairs of matched sections were
examined. The majority of neural crest-derived cells migrating within the outﬂow
tract in control embryos [A, C, E] express connexin 40 at the cell surface and in
contact with neighboring cells. In Hand2 mutant embryos, only a few neural crest-
derived cells maintain expression of connexin 40 [B, D, E]; the expression pattern
appears normal in those few cells that maintain connexin 40. The arrows point to
connexin 40 expressed in the myocardium. Abbreviation: Cx40 (connexin 40).
Fig. 7. Connexin 40 is a direct Hand2-target gene. [A] Schematic representation of the E-
boxes (consensus: CANNTG) located within genomic region 5′ to Exon 1 (ExI) of the
Cx40 gene. Amplicons of the distal (Cx40 [−1144 to −814]) and proximal (Cx40
[−655 to−283]) primer sets (arrows) used for ChIP assays are denoted. [B] ChIP using
a Hand2-speciﬁc antibody co-immunoprecipitates DNA fragments overlapping the
proximal (Cx40 [−655 to−283]), but not distal (Cx40 [−1144 to−814]), primer sets,
indicating that Hand2 binds to the Cx40 promoter within this region. [C] Luciferase-
reporter transactivation assays in HEK 293 cells show that Hand2 and E12 cooperatively
up-regulate expression of a Cx40-luciferase reporter (Cx40-pX2P) ∼2.2 fold over
baseline (n=3, Pb .001). Individually, Hand2 and E12 do not signiﬁcantly inﬂuence
Cx40-pX2P expression.
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D3, and which is required for the G0 to G1 transition (Malumbres and
Barbacid, 2005). Additional genes coding proteins that have a role in cell
cycle regulation were also identiﬁed. Insm1 (Insulinoma associated 1)
was of particular interest because it has been identiﬁed as a member
of a transcription factor network that regulates development of
neural crest-derived noradrenergic sympathetic ganglion neurons
(Howard, 2005; Hendershot et al., 2008; Wildner et al., 2008; Parlier
et al., 2008). Hand2 has a central role in this pathway and likely
functions upstream or in parallel with Insm1 (Hendershot et al.,
2008; Lan and Breslin, 2009). Targeted deletion of Hand2 or Insm1
results in a marked decrease in proliferation of the pool of neural
precursor cells (Hendershot et al., 2008; Wildner et al., 2008). A
potential site of Insm1 activity in the heart is at cyclin D1. Insm1
binds to cyclin D1 (Liu et al., 2006) which competes for the inter-
action of cyclin D1 with Cdk4. The Cdk4/cyclin D1 interaction is
required for proper phosphorylation of retinoblastoma protein Prb
necessary for cell cycle progression from G0 to G1 (Zhang et al.,
2009). The putative Insm1 interacting protein, CAP1 (adenylatecyclase associated protein; Xie et al., 2002) transcript level was also
increased (↑7.21) in the mutant hearts. Interestingly, transcripts
encoding peripherin, a neuron speciﬁc gene and associated with
Hand2 and Insm1was down-regulated 6.41 fold in themutant hearts.
Expression of several histones was also affected by deletion of Hand2
including: 1) histone cluster 1 (↓2.1; Hist1h2bb); 2) H2a histone family
member V (↓2.27); 3)H3 histone family 3B (↓2.55); and 4) histone cluster
2 H2be (↓2.67). Although the nucleosome (core histone complex) is
associated with multiple aspects of DNA replication, repair and
chromatin structure, one of these histones, H2be, is required for Cdk6
to bind its substrate, retinoblastoma protein Prb, required for initiation
of cell cycle progression from G to S phase (Zhao et al., 2000; Marzluff
et al., 2002; Jaeger et al., 2005; Ewen, 2009). Although we found a
signiﬁcant reduction in cell proliferation (Fig. 4G), there is no signiﬁcant
reduction in the percentage of cells that initiate mitosis (Fig. 4H)
suggesting a potential role for Hand2 in regulation of cell cycle
progression.
Genes associated with VSD and DORV
A number of genes have been identiﬁed as risk loci for VSDs and
DORV. We were very interested in these genes since targeted dele-
tion of Hand2 in the neural crest results in these defects in 100% of
embryos examined (Fig. 2). Sox11 (↓2.5), a member of the SRY-related
HMG-box family of transcriptional regulatory genes is an important
regulatory gene affecting neural, skeletal and cardiac development.
Sox11 null embryos develop VSDs with 100% penetrance (Sock et al.,
2004). These embryos also display DORV and other OFT defects similar
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C2H2-type zinc ﬁnger protein) was identiﬁed as a VSD susceptibility
gene in a study focused on 12q13 chromosomal region previously
identiﬁed as associated with occurrence of VSD in humans (Qui et al.,
2006). Although the molecular mechanism of Gli function in the
cardiac neural crest is not yet known, Gli-family members mediate
sonic hedgehog (Shh) signaling (teWelscher et al., 2002a,b; Stamataki
et al., 2005) and Zic3 translocation to the nucleus appears dependent
upon Gli3 (Bedard et al., 2007). Disruption of Zic3 expression results in
a number of developmental defects related to left–right asymmetry
including conotruncalmalformations (Mégarbané et al., 2000;Ware et
al., 2006). Mutations in Foxc1 (↓3.73; forkhead-winged helix tran-
scription factor family) are associated with abnormal vasculogenesis,
coarctation of the aortic arch, and VSDs, related to Notch signaling
(Kumeet al., 2001; Seo et al., 2006); the only linkage toNotch signaling
in our array is Hey1 (↓2.0). Notch signaling has been implicated as
important for septation and Hey 1 (hairy and enhancer of split-related
family of bHLH-type transcriptional repressor) is a Notch-downstream
target gene (Sakata et al., 2002). In conjunction with Hey 2 (not
regulated) Hey 1 has been implicated in Notch-mediated epithelial–
mesenchymal transition (EMT) (Fischer et al., 2004; Niessen and
Karsan, 2008). This occurs via a decrease in expression of several
metalloproteinases (MMP; Brou et al., 2000). Two MMPs, MMP14
(↓2.02) and Adam 19 (↓2.16) were down-regulated in response to
deletion of Hand2 in the cardiac neural crest suggesting that the
reduction in migration and invasion of the cardiac cushions could be
related to decreased expression of these genes.
Valvulogenesis
The cardiac cushions develop in the distal portion of the com-
mon OFT and between the common atria and ventricle (reviewed
in Barnett and Desgrosellier, 2003; Goodwin et al., 2005). Cushion
formation requires production of extracellular matrix material
that becomes situated between the endocardial and myocardial
layers of the developing heart. Neural crest-derived cells contrib-
ute to the truncal cushions that eventually form the aorticopul-
monary septum and semilunar valves (de Lange et al., 2004). A
number of genes associated with aspects of cardiac cushion
formation, valvulogenesis and/or septation have been identiﬁed
and which are affected by targeted deletion of Hand2 in the neural
crest. In the absence of Nf-ATc (nuclear factor of activated T-cells)
heart valves fail to form and embryos die (de la Pompa et al., 1998;
Zhou et al., 2002). Expression of NF-ATc1 is induced by NF-ATc2
(↓2.29) that is down-regulated in response to Hand2-deletion in
the neural crest. Collagen type XI a1 (Col11a1, ↓2.1 array vs. ↓1.43
PCR) is expressed in the non-cartilaginous tissue of the heart.
Mutations in the Col11a1 gene have been implicated in valve
defects. Adam 19 (↓2.16 array vs. ↓2.63 qRT-PCR) is a metallopro-
tease that is expressed in the endocardial cushion. Adam 19 null
mice die within a week of birth due to thickened and misshapen
semilunar valves, tricuspid valves, and membranous VSD (Horiuchi
et al., 2005; Komatsu et al., 2007). EMT is required for proper
cardiac cushion transformation (Barnett and Desgrosellier, 2003)
and is stimulated by members of the transforming growth factor-β
family of proteins. Deletion of latent transforming growth
factor beta binding protein 1 (Ltbp1, ↓2.13) results in multiple
heart defects including improper septation of the OFT, patent
truncus arteriosus (PTA), and interrupted aortic arch (IAA) (Todorovic
et al., 2007).
Discussion
The consequences to loss ofHand2 in the heart have been a focus of
much investigation (Srivastava et al., 1997; Yamagishi et al., 2001;
McFadden et al., 2005; Morikawa and Cserjesi, 2008; Reviewed inFirulli and Thattaliyath, 2002; Firulli, 2003; Bhattacharya et al., 2006;
Olson, 2006; Srivastava, 2006). Hand2 contributes to normal devel-
opment of both the OFT and right ventricular myocardium. Cells from
the secondary heart ﬁeld and cardiac neural crest contribute to the
OFT by migrating into the formed heart tube, whereas only secondary
heart ﬁeld cells contribute to right ventricle myocardium develop-
ment (reviewed in Kelly and Buckingham, 2002; Garry and Olson,
2006; Hutson and Kirby, 2007). Since Hand2 is expressed within the
second heart ﬁeld myocardium and cardiac neural crest it has been
difﬁcult to separate effects of Hand2 deletion in neural crest-derived
or mesoderm-derived components of the heart because of the close
interaction of cells from these two lineages. This problem has been
addressed in the current studies. We employed an intercross of our
mice harboring a Hand2 conditional allele with the Wnt1-Cre
transgenic mouse line to interrogate the consequences to loss of
Hand2 speciﬁcally in the neural crest. Our analysis of OFT develop-
ment combined with gene proﬁling data demonstrates that Hand2-
target genes fall into a variety of functional categories including cell
adhesion, cell cycle regulation, proliferation control and intracellular
signaling. We have identiﬁed a large number of genes as likely or
identiﬁed loci for neural crest-dependent cardiac developmental
anomalies, including VSD, DORV, and valve malformation.
Hand2 gene dosage and cardiac development
Conditional inactivation of Hand2 in secondary heart ﬁeld cells
presages malformation of the right ventricle manifesting as ventric-
ular hypoplasia and in the conotruncus resulting in membranous
ventricular septal defects (VSDs. Speciﬁc deletion of Hand2 in neural
crest-derived cells that contribute to the conotruncus results in
developmental abnormalities expected based on expression pattern.
Interestingly, occurrence of OFT anomalies and VSDs was not
predicted to be prevalent in Hand2ﬂ/ﬂ;Wnt1-Cre embryos because of
potential redundant function with Hand1, which is co-expressed with
Hand2 in a subset of cardiac neural crest cells (McFadden et al., 2005).
Deletion of Hand1 in neural crest-derived cells does not affect
phenotypically, embryonic development. However, in these same
mice, Hand2 haploinsufﬁciency, due to deletion in the ventrolateral
branchial arch, shows novel defects in cranio-facial neural crest-
derived structures (Yanagisawa et al., 2003; Barbosa et al., 2007). We
observe clear defects in the cardiac neural crest of Hand2ﬂ/ﬂ;Wnt1-Cre
embryos, where Hand1 is co-expressed, suggesting that Hand2
function would be dominant to that of Hand1; these closely related
transcriptional regulators do not appear to have redundant functions
related to migration or differentiation of cardiac neural crest. Our data
suggest that Hand1 and Hand2 have unique functions in the cardiac
neural crest.
The defect we observe in right ventricle development in the Hand2
hypomorph embryos, disorganized trabeculations and thin ventricu-
lar wall, was predictable given that Hand1 expression is low (albeit
undetectable) within the right ventricle. The phenotypic character-
istics we describe in both Hand2ﬂ/ﬂ;Wnt1-Cre and Hand2ﬂneo/ﬂneo
embryos supports previous data suggesting that Hand2 protein
function is dosage dependent (McFadden et al., 2005; Firulli et al.,
2005; Hendershot et al., 2008). The phenotype observed in the Hand2
hypomorph embryos compared to loss of Hand2 in neural crest-
derived cardiac structures underscores the complex functional
interactions that the Twist family of bHLH proteins exhibits in-vivo
(Firulli et al, 2003, 2005; Barnes and Firulli, 2009); our data indicate a
complex pattern of interaction between different cell types that
express Hand2. The nature of the defects we observe in both the
Hand2 hypomorph embryos andHand2 neural crest-speciﬁc knockout
embryos attests to the utility of our genetic model. Because of the
acknowledged importance of gene dosage in Hand factor function,
the Hand2 hypomorph allele will provide a valuable tool for future
examination of phenotypic response to misexpression of Hand2
301K.L. Holler et al. / Developmental Biology 341 (2010) 291–304as well as genetic and functional interaction of Hand2 with other
transcriptional regulators.
Outﬂow tract defects
In the mouse, formation of the septum and valves initiates
between E9.5 and E10 (Webb et al., 1998; Jiang et al., 2000). Cells in
the OFT undergo an EMT andmigrate into the cardiac jelly (Song et al.,
2000; Camenisch et al., 2002; Gitler et al., 2003; Person et al., 2005);
these cells derive from the neural crest and the endocardium (Runyan
and Markwald, 1983; Camenisch et al., 2000; Kisanuki et al., 2001). In
conjunction with cells located in the AV canal (endocardial origin),
neural crest-derived cells will form the membranous septum and
valves (Runyan and Markwald, 1983, Poelmann et al., 1998; De Lange
et al., 2004). Formation of the aorticopulmonary septation complex
involves neural crest-derived cells and non-neural crest-derived cells
in the conotruncal ridges (Waldo et al., 1998). Neural crest-derived
cells form the prongs of the aorticopulmonary septum at around E9.5
(Waldo et al., 1998, 1999; Kisanuki et al., 2001); these prongs of cells
eventually form parts of both the aorta and pulmonary structures,
valves and arterial smooth muscle (Waldo et al., 1998). Our results
indicate that formation of the AP prongs is affected by loss of Hand2 in
the neural crest-derived cells that migrate into the OFT. The reduced
cell density and apparent decrease of cell–cell contact between the
migrating cells is reﬂected in altered expression of a number of genes
associated with these functions.
Formation of the OFT septum begins at around E10.5 (Jiang et al.,
2002). The defects that we observe in septation and OFT vessel
formation likely result from a substantial reduction in the number of
neural crest-derived cells that form the AP prongs. At E9.5 neural
crest-derived cells are located proximal to the aortic sac and initiating
migration through it to the truncus arteriosus (Jiang et al., 2002). Later
in development, the OFT will form the aortic and pulmonary OFT
vessels as the aorticopulmonary septum forms at the distal pole and
the conotruncal septum forms at the proximal end. The outﬂow valves
form concurrently. Our results demonstrate that Hand2 is required for
these morphogenetic events to proceed properly. As described
previously (Morikawa and Cserjesi, 2008), the absence of Hand2 in
cardiac neural crest causes misalignment of the aortic arch arteries
and OFT. Our data suggest that cell–cell communication, mediated by
gap junctions, constitutes a critical component of signaling in the
cardiac neural crest; anomalies in vessel alignment and septation
appear to occur, in part, as a result of decreased expression of Cx40 in
neural crest-derived cells. The reduction in Cx40 expression appears
to be a direct result of Hand2 loss-of-function since our data indicate
that Cx40 is a direct target of Hand2.
Cell–cell contact and intercellular signaling via gap junctions have
been associated with cell cycle control (Lowenstein, 1988) and neural
crest migration (Huang et al., 1998; Lo et al., 1997). Both gain-of-
function of connexin 43 in the neural crest and systemic loss-of-
function of connexin 43 results in defective development of the
conotruncus as well as the pulmonary outﬂow vessel (Reaume et al.,
1995; Ewart et al., 1997; Huang et al., 1998; Sullivan et al., 1998;
Simon et al., 2004). It is clear from these previous studies that
expression levels of connexin proteins in the neural crest is critical
and contributes to development of the OFT; Cx40 has not previously
been reported in the neural crest. Importantly, it appears that Hand2
directly affects expression of Cx40 in the developing OFT. It will be
interesting in future studies to validate other Hand2 targets or
interacting molecules identiﬁed in our mRNA screen and validated as
potential direct Hand2 targets in out ChIP-on-chip screen that are
involved in cell–cell contact and migration in OFT formation. Based
on our gene proﬁling, expression of connexin 43 was not altered by
deletion of Hand2 in the neural crest. We provide evidence that in the
absence of Hand2, neural crest-derived cells migrating within the OFT
do not migrate as a coherent sheet of cells as they normally do(Bancroft and Bellairs, 1976; Davis and Trinkaus, 1981; Raible and
Eisen, 1996; Gammill et al., 2006; Kuriyama and Mayor; 2008). It is
interesting to note however, that the extent of migration is not
adversely affected by Hand2 deletion. Although we did not detect any
notable difference in the length of the OFT in Hand2mutant embryos,
the apparent reduction in the numbers of neural crest-derived cells
coupled with the decreased adhesion that we observe in the AP
prongs suggests that it is aberrant remodeling affecting proper
generation of the aorticopulmonary septation complex that contrib-
utes to generation of DORV and VSD.
Interestingly, in about 20% of the hearts that we examined, we
found neural crest-derived cells that had tracked incorrectly and
migrated into the ventricles. Although we did not observe any
apparent effect of these mis-located neural crest-derived cells on
ventricle development, abnormal ventricle development has been
reported previously using an independently derived line of ﬂoxed
Hand2mice (Morikawa and Cserjesi, 2008). These authors concluded
that loss-of-Hand2 function in cardiac neural crest induced prolifer-
ation of cardiomyocytes resulting in enlarged right ventricles
(Morikawa and Cserjesi, 2008). This was an intriguing ﬁnding because
neural crest-derived cells do not normally contribute to myocardial
development although expression of Hand2 in cardiomyocytes is
necessary for right ventricle development (Srivastava et al., 1997). The
hypertrabeculations observed in thesemutant hearts is reminiscent of
what we observe in our Hand2 hypomorphic embryos. It is likely that
this reported aberrant right ventricle development was in fact a
primary hypomorphic phenotype within the cardiomyocytes, as this
group observed hypomorphic phenotypes from their ﬂoxed Hand2
mice (Morikawa et al., 2007); in these embryos, although targeted
Hand2 deletion in the neural crest would give rise to the expected
defects in OFT development, misexpression of Hand2 in the right
ventricle would be expected to affect trabeculations and cell cycle.
Neural crest cell cycle regulation
In the peripheral nervous system Hand2 is required for neurogen-
esis and neurotransmitter speciﬁcation and expression in noradren-
ergic sympathetic ganglion neurons (Howard et al., 1999, 2000; Wu
and Howard, 2002; Xu et al., 2003; Hendershot et al., 2007, 2008;
Morikawa et al., 2007; Schmidt et al., 2009). One important function
of Hand2 is in cell cycle regulation; in the absence of Hand2 neural
precursor cells cease to divide (Hendershot et al., 2008).We identiﬁed
a number of cell cycle and proliferation genes regulated downstream
of Hand2 in the heart. The number of cells that populate the OFT is
reduced following targeted deletion of Hand2 in the neural crest; this
could occur as a result of aberrant migration, decreased proliferation
and/or abnormal cell cycle regulation; gene proﬁling suggests that all
of these events are affected in the mutant hearts. The appropriate
number of cells in the AP prongs of neural crest-derived cells that
move into the truncal cushions is required for elongation of the
conotruncus and septation into the aortic and pulmonary trunks. The
abnormal pattern of migration, decreased cell numbers and loss of
cell–cell signaling likely contribute to the formation of VSDs observed
in all mutant embryos. Normal closure of the membranous septum
involves three coordinated morphogenetic events: the muscular
septum must grow upwards, the endocardial cushions must form
the inlet septum (AV canal) and the formation of outlet septum by
growth of the conotruncal ridges must occur (Webb et al., 1998;
Lamers and Mooreman, 2002; Raid et al., 2009). As part of this fusion,
the valves are also formed. We observed in 100% of mutant embryos
DORV that may have developed as a consequence of the development
of VSD (Yelbuz et al., 2002; Xu et al., 2004) or due to themisalignment
of the great vessels (described in Morikawa and Cserjesi, 2008)
observed in embryos with neural crest targeted deletions of Hand2.
Abnormal development of the cardiac cushions could contribute to
the generation of these defects. Mis-regulation of transit through the
302 K.L. Holler et al. / Developmental Biology 341 (2010) 291–304cell cycle, resulting in a decreased number of neural crest-derived
cells populating the AP prongs likely affects truncal cushion devel-
opment and septation. Based on the proﬁle of Hand2-trancriptioanl
targets and the array of proliferation/cell cycle genes modulated by
loss of Hand2, we suggest that the cell cycle is arrested/delayed in G1
or S phase, a situation that would account for a reduction in cells while
maintaining a stable proportion of cells in M phase.
Cardiac cushion and valve development
Proper patterning and differentiation of the cardiac cushions are
required for formation of the semilunar valves and aorticopulmonary
septation. In order for the cardiac cushions to develop extracellular
matrix must be deposited into the acellular cardiac jelly. In order for
valves to form, EMT must occur to remodel the cushions (Wang et al.,
2004). Genes associated with transcriptional control (Nf-ATc; Foxc1,
Foxp1), extracellular matrix composition (collagen XI a1; Ltbp1) and
protein modifying enzymes (metalloproteases), all associated with
aspects of cardiac cushion development, were affected by deletion of
Hand2; a number of these genes are likely direct Hand2 targets. The
cardiac phenotype of mouse embryos deﬁcient in Nf-ATc, FoxP1, and
Sox11 show nearly identical defects resulting from problems in
cardiac cushion development (de la Pompa et al., 1998; Ranger et al.,
1998; Kume et al., 2001; Wang et al., 2004; Sock et al., 2004). Pre-
viously none of these genes has been associated with Hand2. Hand2
is a BMP-downstream target (Howard et al., 2000; Liu et al., 2005b).
BMP is an important signaling molecule regulating aspects of OFT
development including cushion transition and valvulogenesis
(reviewed in Délot, 2003; Jia et al., 2007).
Generation of VSD and DORV
Conditional targeted deletion of Hand2 in the neural crest resulted
in DORV with associated VSD with 100% penetrance. Additionally, we
identiﬁed a number of Hand2-target genes correlated with or iden-
tiﬁed as susceptibility loci for VSD and/or DORV (Zhang et al., 2006).
We identiﬁed Gli3 as a direct Hand2 target and whose expression is
signiﬁcantly reduced as a consequence to loss of Hand2 in cardiac
neural crest. The decreased expression of Gli3 is of interest as Gli3 has
been identiﬁed as a susceptibility locus for VSD (Qui et al., 2006) and
is associated with Hand2 expression and function in the developing
limb bud (te Welscher et al., 2002a,b; Liu et al., 2005a; Barnes and
Firulli, 2009). Gli3 represses sonic hedgehog (SHH), a signaling
molecule associated with second heart ﬁeld development but not
associated with OFT morphogenesis (Dyer and Kirby, 2009). Sox11 is
another gene associated with DORV and VSD (Sock et al., 2004) that
we identiﬁed as a direct Hand2 target and which is down-regulated in
the neural crest in response to deletion of Hand2. A number of genes
regulated in response to deletion of Hand2, which we showed to be
direct Hand2 targets and regulated in the neural crest, (Hey1, Foxc1,
Mmp14) are related to the Notch signaling pathway. Notch signaling
is implicated in migration and development of the cardiac cushions.
Expression of Hand2 in neural crest-derived neural precursor cells
down-regulates expression of Hes1 (Howard unpublished result);
Hey 1 is regulated in the cardiac neural crest. This intriguing result
raises the possibility of identifying networks of Hand2-target genes
that affect cell cycle and cell–cell contact in a number of differenti-
ating cell types but which together mediate morphogenetic move-
ments, proliferation and differentiation.
The constellation of birth defects associated with disrupted
development of the OFT appears to represent a common phenotype
susceptible to multiple sites of regulation. The results of our gene
proﬁling have identiﬁed Hand2 as a critical transcriptional regulatory
factor that directly or indirectly impacts expression of genes
associated with all aspects of OFT development. Given the complexity
of OFT morphogenesis and the role Hand2 plays in multiple celllineages that contribute to its formation, our studies add insight into
the cell autonomous neural crest contributions to OFTmorphogenesis.
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